Clinical Trial Update: Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide

View source ↗

Summary

The trial investigates fecal calprotectin levels in mycophenolate mofetil–induced diarrhea and evaluates octreotide as a treatment in immunosuppressed patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Diarrhea, Immunosuppression | Status: UNKNOWN